CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing public awareness about the therapeutic potency of stem cell products
4.1.2. Technological advancements in stem cell manufacturing and preservation
4.1.3. Rising public-private investments and funding in stem cell-based research
4.1.4. Development of advanced genomic analysis techniques for quality control during stem
cell manufacturing
4.2. Market Restraints & Challenges
4.2.1. Technical limitations associated with manufacturing scale-up
4.2.2. Significant operational costs associated with stem cell manufacturing and banking
4.3. Market Opportunities
4.3.1. Supportive government regulations across developing countries
4.3.2. Increased market focus on embryonic stem cells (ESCS) and induced pluripotent stem
cells
CHAPTER 5. GLOBAL STEM CELL MANUFACTURING MARKET – BY
PRODUCT
5.1. Introduction
5.2. Stem cell lines
5.2.1. Induced Pluripotent Stem Cells
5.2.2. Embryonic Stem Cells
5.2.3. Multipotent Adult Progenitor Stem Cells
5.2.4. Mesenchymal Stem Cells
5.2.5. Hematopoietic Stem Cells
5.2.6. Neural Stem Cells
5.3. Instruments
5.3.1. Bioreactors and Incubators
5.3.2. Cell Sorters
5.3.3. Other Instruments
5.4. Culture Media
5.5. Consumables
CHAPTER 6. GLOBAL STEM CELL MANUFACTURING MARKET – BY
APPLICATION
6.1. Introduction
6.2. Research application
6.2.1. Drug discovery and development
6.2.2. Life science research
6.3. Clinical applications
6.3.1. Allogenic stem cell therapy
6.3.2. Autologous stem cell therapy
6.4. Cell and tissue banking
CHAPTER 7. GLOBAL STEM CELL MANUFACTURING MARKET – BY END USER
7.1. Introduction
7.2. Pharmaceutical and biotechnology companies
7.3. Hospitals and surgical centres
7.4. Academic institutes, research laboratories, and CROS
7.5. Cell banks and tissue banks
7.6. Other end users
CHAPTER 8. GLOBAL STEM CELL MANUFACTURING MARKET - BY
GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL STEM CELL MANUFACTURING MARKET - COMPANY
PROFILES
9.1. Pluristem Therapeutics Inc.
9.2. Holostem Terapie Avanzate.
9.3. Lonza Group.
9.4. MEDIPOST Co., Ltd.
9.5. Cellular Dynamics International, Inc.
9.6. Anterogen Co
9.7. Osiris Therapeutics, Inc.
9.8. STEMCELL Technologies Inc.
9.9. TAKARA BIO INC.
9.10. Pharmicell.
9.11. Miltenyi Biotec.
9.12. Bio-Rad Laboratories, Inc.
9.13. Becton, Dickinson and Company
9.14. Thermo Fisher Scientific
9.15. The Merck Group
CHAPTER 10. GLOBAL STEM CELL MANUFACTURING MARKET COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
